The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing. The Programme aims to support European bodies and Member States in the enactment of European Council Recommendations and Communications on seasonal influenza immunisation and pandemic preparedness.This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States. Published in the Science, 36 (4), 25 Jan 2018.Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. It was reviewed by clinical, epidemiological and virological experts.
Ultimately, EISN aims to contribute to reducing the burden of disease associated with influenza in Europe.Virological surveillance activities are coordinated through the European Reference Laboratory Network for Human Influenza (ERLI-Net), a sub-network within EISN.Weekly analysis of influenza surveillance is available at The following epidemiological and virological influenza surveillance data are collected through The European Surveillance System (TESSy) database hosted by ECDC:On an operational level, EISN consists of operational contact points for influenza epidemiology and virology. At the US Centers for Disease Control and Prevention (CDC), a new effort is under way to assist states in creating or enhancing localized COVID-19 dashboards and maps for the public. The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Influenza viruses that commonly circulate in swine are called “swine influenza viruses” or “swine flu viruses.” Like human influenza viruses, there are different subtypes and strains of swine influenza viruses. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. The network combines epidemiological and virological surveillance of influenza to provide decision makers and public health experts in EU/EEA Member States with the information required to better assess influenza activity in Europe and take appropriate action. Online dashboard from Johns Hopkins University developed to visualize and track reported cases of 2019-nCoV on a daily timescale. Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. From 1999 until September 2006, EISS was funded by the European Commission (DG Sanco). ECDC and the European Maritime Safety Agency (EMSA) have published guidance on the gradual resumption of cruise ship operations in the European Union in relation to the COVID-19 pandemic. The influenza virus characterisation reports give an overview of circulating influenza viruses in Europe. It is caused by influenza virus and is easily transmitted, predominantly via the droplet and contact routes and by indirect spread from respiratory secretions on hands etc. Influenza pandemics happen when a new strain of a flu virus appears which can infect humans, to which most people have no immunity and which can transmit efficiently from human to human. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season.